Your browser doesn't support javascript.
loading
Cost-Effectiveness of Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate versus Dual Therapies in Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease: United Kingdom Analysis Using the ETHOS Study.
de Nigris, Enrico; Treharne, Catrin; Brighton, Nick; Holmgren, Ulf; Walker, Andrew; Haughney, John.
Afiliación
  • de Nigris E; Formerly of Global Product and Portfolio Strategy, AstraZeneca, Cambridge, UK.
  • Treharne C; Formerly of Health Economic Modelling, Regulatory and Access, Parexel International, London, UK.
  • Brighton N; Formerly of Health Economic Modelling, Regulatory and Access, Parexel International, London, UK.
  • Holmgren U; Real World Science and Digital, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden.
  • Walker A; Salus Alba, Glasgow, UK.
  • Haughney J; Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, UK.
Int J Chron Obstruct Pulmon Dis ; 17: 2987-3000, 2022.
Article en En | MEDLINE | ID: mdl-36444374
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas / Peloideterapia Asunto principal: Enfermedad Pulmonar Obstructiva Crónica / Glicopirrolato Tipo de estudio: Diagnostic_studies / Health_economic_evaluation / Prognostic_studies Idioma: En Revista: Int J Chron Obstruct Pulmon Dis Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas / Peloideterapia Asunto principal: Enfermedad Pulmonar Obstructiva Crónica / Glicopirrolato Tipo de estudio: Diagnostic_studies / Health_economic_evaluation / Prognostic_studies Idioma: En Revista: Int J Chron Obstruct Pulmon Dis Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido